发明名称 |
PHARMACEUTICAL COMPOSITIONS CONTAINING CLOSTRIDIUM DIFFICILE TOXOIDS A AND B |
摘要 |
This invention relates to compositions including Clostridium difficile toxins and/or toxoids and corresponding methods. The compositions of the invention include one or more excipients that increase stability and/or decrease aggregation of the toxins. |
申请公布号 |
US2016317640(A1) |
申请公布日期 |
2016.11.03 |
申请号 |
US201615083428 |
申请日期 |
2016.03.29 |
申请人 |
Sanofi Pasteur Biologics, LLC |
发明人 |
MIDDAUGH C. Russell;FAHRNER Richard;CIARAMETARO Peter |
分类号 |
A61K39/08;A61K47/08;A61K47/12;A61K47/26 |
主分类号 |
A61K39/08 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of inducing an immune response to Clostridium difficile in a subject, the method comprising administering to the subject a composition comprising a toxin or a toxoid of C. difficile and one or more pharmaceutically acceptable excipients, wherein the one or more pharmaceutically acceptable excipients increases thermal stability of the toxin or toxoid and/or reduces or delays aggregation of the toxin or toxoid, relative to a composition lacking the one or more pharmaceutically acceptable excipients. |
地址 |
Cambridge MA US |